Table 3.
Antibiotics resistant pattern of nasal and perirectal enterococci by disc diffusion method
|
Antibiotic discs (abbreviations) |
Nasal isolates |
Perirectal isolates |
||
|---|---|---|---|---|
| |
(n = 29) |
(n = 56) |
||
| E. faecalis (n = 11) | E. faecium (n = 18) | E. faecalis (n = 29) | E. faecium (n = 27) | |
|
% Resistance | ||||
|
Co-amoxyclav 30 μg (AMC30) |
36.4 |
50 |
13.8 |
70.4 |
|
Ampicillin 25 μg (AMP25) |
36.4 |
50 |
13.8 |
70.4 |
|
Cefoxitin 30 μg (FOX30) |
100 |
100 |
93.1 |
100 |
|
Cephalexin 30 μg (CL30) |
90.9 |
77.8 |
100 |
96.3 |
|
Cephalothin 30 μg (KF30) |
81.8 |
66.7 |
75.9 |
96.3 |
|
Cephradine 30 μg (CE30) |
81.8 |
94.4 |
100 |
100 |
|
Ciprofloxacin 5 μg (CIP5) |
81.8 |
66.7 |
69 |
96.3 |
|
Erythromycin 15 μg (E15) |
90.9 |
88.9 |
79.3 |
96.3 |
|
Gentamicin 30 μg (CN30) |
72.7 |
83.3 |
79.3 |
92.6 |
|
Imipenem 10 μg (IPM10) |
45.5 |
55.6 |
24.1 |
85.2 |
|
Levofloxacin 5 μg (LEV5) |
45.5 |
50 |
62.1 |
92.6 |
|
Linezolid 30 μg (LZD30) |
0 |
0 |
0 |
0 |
|
Methicillin 10 μg (MET10) |
100 |
100 |
96.6 |
100 |
|
Oxacillin 1 μg (OX1) |
100 |
100 |
100 |
100 |
|
Penicillin G 10 IU (P10) |
36.4 |
55.6 |
31 |
85.2 |
|
Quinupristin/Dalfopristin 15 μg (QD15) |
0 |
0 |
0 |
0 |
|
Teicoplanin 30 μg (TEC30) |
18.2 |
5.6 |
10.3 |
11.1 |
|
Tetracycline 30 μg (TE30) |
36.4 |
50 |
75.9 |
70.4 |
| Vancomycin 30 μg (VA30) | 18.2 | 5.6 | 10.3 | 11.1 |